Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance-Reference-Cited by-同舟云学术

Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance

Published:2006-04 Issue:3 Volume:160 Page:217-224
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Dzamitika Simplice A.,Falcão Camila A.B.,de Oliveira Fernanda B.,Marbeuf Carole,Garnier-Suillerot Arlette,Demicheli Cynthia,Rossi-Bergmann Bartira,Frézard Frédéric

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference29 articles.

1. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years;Berman;Clin. Infect. Dis.,1997

2. Pentavalent antimonials: from chemistry to the design of new drugs;Demicheli;Drug Des. Rev. – Online,2005

3. Anticancer activity of sodium stibogluconate in synergy with IFNs;Yi;J. Immunol.,2002

4. Arsenic and antimony: comparative approach on mechanistic toxicology;Gebel;Chem. Biol. Interact.,1997

5. Thiol-induced reduction of antimony(V) into antimony(III): a comparative study with trypanothione, cysteinyl-glycine, cysteine and glutathione;Ferreira;BioMetals,2003

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supramolecular assemblies from antimony(V) complexes for the treatment of leishmaniasis;Biophysical Reviews;2023-06-06

2. Leishmaniasis: Biology, clinical diagnosis, and treatment;Viral, Parasitic, Bacterial, and Fungal Infections;2023

3. Antimony;Handbook on the Toxicology of Metals;2022

4. Antileishmanial Drug Discovery and Development: Time to Reset the Model?;Microorganisms;2021-12-02

5. Multivariate Optimization Applied to the Synthesis of Meglumine Antimoniate with Low Levels of Trivalent Antimony;Journal of the Brazilian Chemical Society;2021